| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Puma Biotechnology, Inc.
13D/A
PBYI · 74587V107
|
16.0% |
10/6/2026
Event 10/4/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.